Subjective Evaluation of a Commercially Marketed Contact Lens Amongst a Subset of the Contact Lens Wearing Population
ClinicalTrials.gov ID
NCT01007916
Lead Sponsor
CIBA VISIONINDUSTRY
Overall Status
Completed
Study Type
Interventional
Phase
Not Applicable
Enrollment
50Actual
Last Update Posted
Jul 10, 2012Estimated
Start Date
Oct 2009
Primary Completion Date
Jan 2010Actual
Completion Date
Jan 2010Actual
Brief Summary
The purpose of this study is to compare the performance of commercially marketed contact lenses to habitual contact lenses in a selected segment of the contact lens wearing population.
Myopia
Lotrafilcon B contact lens
Habitual contact lens
Ages Eligible for Study
Child (0-17)Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Habitual spherical soft contact lens wearer who wears a contact lens with a recommended replacement schedule of 2 weeks or monthly.
Wears lenses at least 5 days per week and at least 12 hours per day.
Removes contact lenses daily or, if prescribed by their regular eye care practitioner, sleeps overnight in contact lenses no more than 6 consecutive nights.
Reports 2 or fewer common lens-related symptoms with current contact lenses with a frequency of "frequently" or "always".
Able to achieve distance visual acuity of at least 20/40 in each eye at the dispense of each pair of study lenses.
Has acceptable or optimal fit for each eye at the dispense of each pair of study lenses.
Other protocol-defined inclusion/exclusion criteria may apply.
Exclusion Criteria:
Eye injury or surgery within twelve weeks prior to enrollment.
Pre-existing ocular irritation that would preclude contact lens fitting.
Currently enrolled in any clinical trial.
Any use of medications for which contact lens wear could be contraindicated as determined by the investigator.
Currently sleeping in contact lenses for more than 6 consecutive nights.
Currently wearing daily disposable contact lenses and certain protocol-specified lens brands.
Other protocol-defined inclusion/exclusion criteria may apply.